People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most ...

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

A global review of dietary patterns has revealed how what we eat profoundly affects our gut health, influencing the risk of ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

In line with the "We the UAE 2031" Vision, the summit focused on improving quality of life and advancing specialized care for ...

Doctors have uncovered a new method of detecting bowel cancer - which is correct in nine out of 10 cases. A study by the Institute of Cancer Research with the help of doctors at specialist bowel ...

As part of their research, scientists developed an algorithm that calculates a person's risk of future bowel cancer based on ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

A recent study finds that physiological metrics from wearable devices can help identify inflammatory bowel disease flares.

Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.